| Mr John E Mertz, MD PHD | |
|
1406 6 Ave N, St Cloud, MN 56301-1901 | |
| (320) 255-5657 | |
| (320) 656-7194 |
| Full Name | Mr John E Mertz |
|---|---|
| Gender | Male |
| Speciality | Emergency Medicine |
| Location | 1406 6 Ave N, St Cloud, Minnesota |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1346217874 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | 43425 (Minnesota) | Primary |
| Entity Name | Centracare Clinic |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1043212665 PECOS PAC ID: 2466363395 Enrollment ID: O20031105000293 |
News Archive
Scientists in Australia and America believe they have found a way to deal with the increasing antibiotic resistance of deadly superbugs such as MRSA.
Enzymatics, Inc., a leading producer of reagents, kits, and assays, today announced it has acquired Boulder-based ArcherDx, Inc., a developer of innovative, NGS-based kits and software solutions for use in investigating cancer treatment.
Agricultural pesticide workers are not only exposed to pesticides from inhalation, but also through their skin. The dermal route of exposure to chlorpyrifos, a common agricultural pesticide, is known to contribute substantially to workers' total exposure
A biomedical engineer at Worcester Polytechnic Institute is creating a new medical robot that uses minimally invasive technologies to safely and accurately detect and monitor prostate cancer, the second-leading cause of cancer-related deaths among American men.
CQDM and Ontario Centres of Excellence will fund five highly innovative and unconventional game-changing research and development projects to accelerate drug discovery in the Quebec-Ontario Life Sciences Corridor. Partners are granting $1.5M to Quebec-based and, for the first time, Ontario-based researchers thanks to the partnership with OCE through CQDM's 2014 Explore Program, one of CQDM's flagship programs focusing on early concept validation of cutting-edge technologies that address the most crucial needs in drug discovery and development.
› Verified 5 days ago
| Entity Name | Emergency Physicians Professional Association |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1801871934 PECOS PAC ID: 9537072657 Enrollment ID: O20031106000068 |
News Archive
Scientists in Australia and America believe they have found a way to deal with the increasing antibiotic resistance of deadly superbugs such as MRSA.
Enzymatics, Inc., a leading producer of reagents, kits, and assays, today announced it has acquired Boulder-based ArcherDx, Inc., a developer of innovative, NGS-based kits and software solutions for use in investigating cancer treatment.
Agricultural pesticide workers are not only exposed to pesticides from inhalation, but also through their skin. The dermal route of exposure to chlorpyrifos, a common agricultural pesticide, is known to contribute substantially to workers' total exposure
A biomedical engineer at Worcester Polytechnic Institute is creating a new medical robot that uses minimally invasive technologies to safely and accurately detect and monitor prostate cancer, the second-leading cause of cancer-related deaths among American men.
CQDM and Ontario Centres of Excellence will fund five highly innovative and unconventional game-changing research and development projects to accelerate drug discovery in the Quebec-Ontario Life Sciences Corridor. Partners are granting $1.5M to Quebec-based and, for the first time, Ontario-based researchers thanks to the partnership with OCE through CQDM's 2014 Explore Program, one of CQDM's flagship programs focusing on early concept validation of cutting-edge technologies that address the most crucial needs in drug discovery and development.
› Verified 5 days ago
| Entity Name | Centracare Health System - Melrose |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1720045073 PECOS PAC ID: 1658270368 Enrollment ID: O20031231000690 |
News Archive
Scientists in Australia and America believe they have found a way to deal with the increasing antibiotic resistance of deadly superbugs such as MRSA.
Enzymatics, Inc., a leading producer of reagents, kits, and assays, today announced it has acquired Boulder-based ArcherDx, Inc., a developer of innovative, NGS-based kits and software solutions for use in investigating cancer treatment.
Agricultural pesticide workers are not only exposed to pesticides from inhalation, but also through their skin. The dermal route of exposure to chlorpyrifos, a common agricultural pesticide, is known to contribute substantially to workers' total exposure
A biomedical engineer at Worcester Polytechnic Institute is creating a new medical robot that uses minimally invasive technologies to safely and accurately detect and monitor prostate cancer, the second-leading cause of cancer-related deaths among American men.
CQDM and Ontario Centres of Excellence will fund five highly innovative and unconventional game-changing research and development projects to accelerate drug discovery in the Quebec-Ontario Life Sciences Corridor. Partners are granting $1.5M to Quebec-based and, for the first time, Ontario-based researchers thanks to the partnership with OCE through CQDM's 2014 Explore Program, one of CQDM's flagship programs focusing on early concept validation of cutting-edge technologies that address the most crucial needs in drug discovery and development.
› Verified 5 days ago
| Entity Name | Cuyuna Regional Medical Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1861414518 PECOS PAC ID: 9537146550 Enrollment ID: O20040707000501 |
News Archive
Scientists in Australia and America believe they have found a way to deal with the increasing antibiotic resistance of deadly superbugs such as MRSA.
Enzymatics, Inc., a leading producer of reagents, kits, and assays, today announced it has acquired Boulder-based ArcherDx, Inc., a developer of innovative, NGS-based kits and software solutions for use in investigating cancer treatment.
Agricultural pesticide workers are not only exposed to pesticides from inhalation, but also through their skin. The dermal route of exposure to chlorpyrifos, a common agricultural pesticide, is known to contribute substantially to workers' total exposure
A biomedical engineer at Worcester Polytechnic Institute is creating a new medical robot that uses minimally invasive technologies to safely and accurately detect and monitor prostate cancer, the second-leading cause of cancer-related deaths among American men.
CQDM and Ontario Centres of Excellence will fund five highly innovative and unconventional game-changing research and development projects to accelerate drug discovery in the Quebec-Ontario Life Sciences Corridor. Partners are granting $1.5M to Quebec-based and, for the first time, Ontario-based researchers thanks to the partnership with OCE through CQDM's 2014 Explore Program, one of CQDM's flagship programs focusing on early concept validation of cutting-edge technologies that address the most crucial needs in drug discovery and development.
› Verified 5 days ago
| Entity Name | Centracare Health System - Long Prairie |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1164471678 PECOS PAC ID: 3870524598 Enrollment ID: O20050823000460 |
News Archive
Scientists in Australia and America believe they have found a way to deal with the increasing antibiotic resistance of deadly superbugs such as MRSA.
Enzymatics, Inc., a leading producer of reagents, kits, and assays, today announced it has acquired Boulder-based ArcherDx, Inc., a developer of innovative, NGS-based kits and software solutions for use in investigating cancer treatment.
Agricultural pesticide workers are not only exposed to pesticides from inhalation, but also through their skin. The dermal route of exposure to chlorpyrifos, a common agricultural pesticide, is known to contribute substantially to workers' total exposure
A biomedical engineer at Worcester Polytechnic Institute is creating a new medical robot that uses minimally invasive technologies to safely and accurately detect and monitor prostate cancer, the second-leading cause of cancer-related deaths among American men.
CQDM and Ontario Centres of Excellence will fund five highly innovative and unconventional game-changing research and development projects to accelerate drug discovery in the Quebec-Ontario Life Sciences Corridor. Partners are granting $1.5M to Quebec-based and, for the first time, Ontario-based researchers thanks to the partnership with OCE through CQDM's 2014 Explore Program, one of CQDM's flagship programs focusing on early concept validation of cutting-edge technologies that address the most crucial needs in drug discovery and development.
› Verified 5 days ago
| Entity Name | Centracare Health System - Melrose |
|---|---|
| Entity Type | Part A Provider - Critical Access Hospital |
| Entity Identifiers | NPI Number: 1720045073 PECOS PAC ID: 1658270368 Enrollment ID: O20060504000839 |
News Archive
Scientists in Australia and America believe they have found a way to deal with the increasing antibiotic resistance of deadly superbugs such as MRSA.
Enzymatics, Inc., a leading producer of reagents, kits, and assays, today announced it has acquired Boulder-based ArcherDx, Inc., a developer of innovative, NGS-based kits and software solutions for use in investigating cancer treatment.
Agricultural pesticide workers are not only exposed to pesticides from inhalation, but also through their skin. The dermal route of exposure to chlorpyrifos, a common agricultural pesticide, is known to contribute substantially to workers' total exposure
A biomedical engineer at Worcester Polytechnic Institute is creating a new medical robot that uses minimally invasive technologies to safely and accurately detect and monitor prostate cancer, the second-leading cause of cancer-related deaths among American men.
CQDM and Ontario Centres of Excellence will fund five highly innovative and unconventional game-changing research and development projects to accelerate drug discovery in the Quebec-Ontario Life Sciences Corridor. Partners are granting $1.5M to Quebec-based and, for the first time, Ontario-based researchers thanks to the partnership with OCE through CQDM's 2014 Explore Program, one of CQDM's flagship programs focusing on early concept validation of cutting-edge technologies that address the most crucial needs in drug discovery and development.
› Verified 5 days ago
| Entity Name | Centracare Health System - Long Prairie |
|---|---|
| Entity Type | Part A Provider - Critical Access Hospital |
| Entity Identifiers | NPI Number: 1164471678 PECOS PAC ID: 3870524598 Enrollment ID: O20061104000579 |
News Archive
Scientists in Australia and America believe they have found a way to deal with the increasing antibiotic resistance of deadly superbugs such as MRSA.
Enzymatics, Inc., a leading producer of reagents, kits, and assays, today announced it has acquired Boulder-based ArcherDx, Inc., a developer of innovative, NGS-based kits and software solutions for use in investigating cancer treatment.
Agricultural pesticide workers are not only exposed to pesticides from inhalation, but also through their skin. The dermal route of exposure to chlorpyrifos, a common agricultural pesticide, is known to contribute substantially to workers' total exposure
A biomedical engineer at Worcester Polytechnic Institute is creating a new medical robot that uses minimally invasive technologies to safely and accurately detect and monitor prostate cancer, the second-leading cause of cancer-related deaths among American men.
CQDM and Ontario Centres of Excellence will fund five highly innovative and unconventional game-changing research and development projects to accelerate drug discovery in the Quebec-Ontario Life Sciences Corridor. Partners are granting $1.5M to Quebec-based and, for the first time, Ontario-based researchers thanks to the partnership with OCE through CQDM's 2014 Explore Program, one of CQDM's flagship programs focusing on early concept validation of cutting-edge technologies that address the most crucial needs in drug discovery and development.
› Verified 5 days ago
| Entity Name | Centracare Health System - Sauk Centre |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1578813762 PECOS PAC ID: 4981857216 Enrollment ID: O20130116000380 |
News Archive
Scientists in Australia and America believe they have found a way to deal with the increasing antibiotic resistance of deadly superbugs such as MRSA.
Enzymatics, Inc., a leading producer of reagents, kits, and assays, today announced it has acquired Boulder-based ArcherDx, Inc., a developer of innovative, NGS-based kits and software solutions for use in investigating cancer treatment.
Agricultural pesticide workers are not only exposed to pesticides from inhalation, but also through their skin. The dermal route of exposure to chlorpyrifos, a common agricultural pesticide, is known to contribute substantially to workers' total exposure
A biomedical engineer at Worcester Polytechnic Institute is creating a new medical robot that uses minimally invasive technologies to safely and accurately detect and monitor prostate cancer, the second-leading cause of cancer-related deaths among American men.
CQDM and Ontario Centres of Excellence will fund five highly innovative and unconventional game-changing research and development projects to accelerate drug discovery in the Quebec-Ontario Life Sciences Corridor. Partners are granting $1.5M to Quebec-based and, for the first time, Ontario-based researchers thanks to the partnership with OCE through CQDM's 2014 Explore Program, one of CQDM's flagship programs focusing on early concept validation of cutting-edge technologies that address the most crucial needs in drug discovery and development.
› Verified 5 days ago
| Entity Name | Centracare Health-paynesville Llc |
|---|---|
| Entity Type | Part A Provider - Critical Access Hospital |
| Entity Identifiers | NPI Number: 1205269941 PECOS PAC ID: 1153555719 Enrollment ID: O20131108000012 |
News Archive
Scientists in Australia and America believe they have found a way to deal with the increasing antibiotic resistance of deadly superbugs such as MRSA.
Enzymatics, Inc., a leading producer of reagents, kits, and assays, today announced it has acquired Boulder-based ArcherDx, Inc., a developer of innovative, NGS-based kits and software solutions for use in investigating cancer treatment.
Agricultural pesticide workers are not only exposed to pesticides from inhalation, but also through their skin. The dermal route of exposure to chlorpyrifos, a common agricultural pesticide, is known to contribute substantially to workers' total exposure
A biomedical engineer at Worcester Polytechnic Institute is creating a new medical robot that uses minimally invasive technologies to safely and accurately detect and monitor prostate cancer, the second-leading cause of cancer-related deaths among American men.
CQDM and Ontario Centres of Excellence will fund five highly innovative and unconventional game-changing research and development projects to accelerate drug discovery in the Quebec-Ontario Life Sciences Corridor. Partners are granting $1.5M to Quebec-based and, for the first time, Ontario-based researchers thanks to the partnership with OCE through CQDM's 2014 Explore Program, one of CQDM's flagship programs focusing on early concept validation of cutting-edge technologies that address the most crucial needs in drug discovery and development.
› Verified 5 days ago
| Entity Name | Centracare Health System - Sauk Centre |
|---|---|
| Entity Type | Part A Provider - Critical Access Hospital |
| Entity Identifiers | NPI Number: 1740553932 PECOS PAC ID: 4981857216 Enrollment ID: O20140523001292 |
News Archive
Scientists in Australia and America believe they have found a way to deal with the increasing antibiotic resistance of deadly superbugs such as MRSA.
Enzymatics, Inc., a leading producer of reagents, kits, and assays, today announced it has acquired Boulder-based ArcherDx, Inc., a developer of innovative, NGS-based kits and software solutions for use in investigating cancer treatment.
Agricultural pesticide workers are not only exposed to pesticides from inhalation, but also through their skin. The dermal route of exposure to chlorpyrifos, a common agricultural pesticide, is known to contribute substantially to workers' total exposure
A biomedical engineer at Worcester Polytechnic Institute is creating a new medical robot that uses minimally invasive technologies to safely and accurately detect and monitor prostate cancer, the second-leading cause of cancer-related deaths among American men.
CQDM and Ontario Centres of Excellence will fund five highly innovative and unconventional game-changing research and development projects to accelerate drug discovery in the Quebec-Ontario Life Sciences Corridor. Partners are granting $1.5M to Quebec-based and, for the first time, Ontario-based researchers thanks to the partnership with OCE through CQDM's 2014 Explore Program, one of CQDM's flagship programs focusing on early concept validation of cutting-edge technologies that address the most crucial needs in drug discovery and development.
› Verified 5 days ago
| Entity Name | Centracare Health-paynesville Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1629402516 PECOS PAC ID: 1153555719 Enrollment ID: O20140909002390 |
News Archive
Scientists in Australia and America believe they have found a way to deal with the increasing antibiotic resistance of deadly superbugs such as MRSA.
Enzymatics, Inc., a leading producer of reagents, kits, and assays, today announced it has acquired Boulder-based ArcherDx, Inc., a developer of innovative, NGS-based kits and software solutions for use in investigating cancer treatment.
Agricultural pesticide workers are not only exposed to pesticides from inhalation, but also through their skin. The dermal route of exposure to chlorpyrifos, a common agricultural pesticide, is known to contribute substantially to workers' total exposure
A biomedical engineer at Worcester Polytechnic Institute is creating a new medical robot that uses minimally invasive technologies to safely and accurately detect and monitor prostate cancer, the second-leading cause of cancer-related deaths among American men.
CQDM and Ontario Centres of Excellence will fund five highly innovative and unconventional game-changing research and development projects to accelerate drug discovery in the Quebec-Ontario Life Sciences Corridor. Partners are granting $1.5M to Quebec-based and, for the first time, Ontario-based researchers thanks to the partnership with OCE through CQDM's 2014 Explore Program, one of CQDM's flagship programs focusing on early concept validation of cutting-edge technologies that address the most crucial needs in drug discovery and development.
› Verified 5 days ago
| Entity Name | Carris Health Llc |
|---|---|
| Entity Type | Part B Supplier - Hospital Department(s) |
| Entity Identifiers | NPI Number: 1134632680 PECOS PAC ID: 7012274228 Enrollment ID: O20180111000831 |
News Archive
Scientists in Australia and America believe they have found a way to deal with the increasing antibiotic resistance of deadly superbugs such as MRSA.
Enzymatics, Inc., a leading producer of reagents, kits, and assays, today announced it has acquired Boulder-based ArcherDx, Inc., a developer of innovative, NGS-based kits and software solutions for use in investigating cancer treatment.
Agricultural pesticide workers are not only exposed to pesticides from inhalation, but also through their skin. The dermal route of exposure to chlorpyrifos, a common agricultural pesticide, is known to contribute substantially to workers' total exposure
A biomedical engineer at Worcester Polytechnic Institute is creating a new medical robot that uses minimally invasive technologies to safely and accurately detect and monitor prostate cancer, the second-leading cause of cancer-related deaths among American men.
CQDM and Ontario Centres of Excellence will fund five highly innovative and unconventional game-changing research and development projects to accelerate drug discovery in the Quebec-Ontario Life Sciences Corridor. Partners are granting $1.5M to Quebec-based and, for the first time, Ontario-based researchers thanks to the partnership with OCE through CQDM's 2014 Explore Program, one of CQDM's flagship programs focusing on early concept validation of cutting-edge technologies that address the most crucial needs in drug discovery and development.
› Verified 5 days ago
| Entity Name | Welia Health |
|---|---|
| Entity Type | Part A Provider - Critical Access Hospital |
| Entity Identifiers | NPI Number: 1528031390 PECOS PAC ID: 6709295496 Enrollment ID: O20210722002959 |
News Archive
Scientists in Australia and America believe they have found a way to deal with the increasing antibiotic resistance of deadly superbugs such as MRSA.
Enzymatics, Inc., a leading producer of reagents, kits, and assays, today announced it has acquired Boulder-based ArcherDx, Inc., a developer of innovative, NGS-based kits and software solutions for use in investigating cancer treatment.
Agricultural pesticide workers are not only exposed to pesticides from inhalation, but also through their skin. The dermal route of exposure to chlorpyrifos, a common agricultural pesticide, is known to contribute substantially to workers' total exposure
A biomedical engineer at Worcester Polytechnic Institute is creating a new medical robot that uses minimally invasive technologies to safely and accurately detect and monitor prostate cancer, the second-leading cause of cancer-related deaths among American men.
CQDM and Ontario Centres of Excellence will fund five highly innovative and unconventional game-changing research and development projects to accelerate drug discovery in the Quebec-Ontario Life Sciences Corridor. Partners are granting $1.5M to Quebec-based and, for the first time, Ontario-based researchers thanks to the partnership with OCE through CQDM's 2014 Explore Program, one of CQDM's flagship programs focusing on early concept validation of cutting-edge technologies that address the most crucial needs in drug discovery and development.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mr John E Mertz, MD PHD 511 9 Ave S, St Cloud, MN 56301-4238 Ph: (612) 227-6312 | Mr John E Mertz, MD PHD 1406 6 Ave N, St Cloud, MN 56301-1901 Ph: (320) 255-5657 |
News Archive
Scientists in Australia and America believe they have found a way to deal with the increasing antibiotic resistance of deadly superbugs such as MRSA.
Enzymatics, Inc., a leading producer of reagents, kits, and assays, today announced it has acquired Boulder-based ArcherDx, Inc., a developer of innovative, NGS-based kits and software solutions for use in investigating cancer treatment.
Agricultural pesticide workers are not only exposed to pesticides from inhalation, but also through their skin. The dermal route of exposure to chlorpyrifos, a common agricultural pesticide, is known to contribute substantially to workers' total exposure
A biomedical engineer at Worcester Polytechnic Institute is creating a new medical robot that uses minimally invasive technologies to safely and accurately detect and monitor prostate cancer, the second-leading cause of cancer-related deaths among American men.
CQDM and Ontario Centres of Excellence will fund five highly innovative and unconventional game-changing research and development projects to accelerate drug discovery in the Quebec-Ontario Life Sciences Corridor. Partners are granting $1.5M to Quebec-based and, for the first time, Ontario-based researchers thanks to the partnership with OCE through CQDM's 2014 Explore Program, one of CQDM's flagship programs focusing on early concept validation of cutting-edge technologies that address the most crucial needs in drug discovery and development.
› Verified 5 days ago
Daniel Lloyd Fark, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 1406 6th Ave N, St Cloud, MN 56303 Phone: 320-255-5657 Fax: 320-656-7194 | |
Dr. Joseph Justis Randolph, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1406 6th Ave N, St Cloud, MN 56303 Phone: 320-255-5657 Fax: 320-656-7194 | |
Peter L Charvat, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 1406 6th Ave N, St Cloud Hospital, St Cloud, MN 56303 Phone: 320-255-5656 | |
Anthony P Haas, MD Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 1406 6th Ave N, St Cloud Hospital, St Cloud, MN 56303 Phone: 320-255-5657 | |
Michael James Severson, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 1406 Sixth Ave N, St Cloud, MN 56301 Phone: 320-255-5656 Fax: 320-656-7194 | |
Brett Thomas Stolzenberg, MD Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 1406 6th Ave No, St Cloud, MN 56303 Phone: 320-255-5657 Fax: 320-656-7194 |